「借花献佛」，和大家分享下推荐最多的 10 本 「案头必备」和 10 本 「床头必备」好书。一、案头必备TOP 1. 实用内科学推荐理由：中国医学界唯一一部畅销...出版一次，已出至第14版，可及时反映国内外进展，是内科领域各级学科医师的 「不二宝典」。TOP 2. 坎贝尔骨科手术学推荐理由：国际权威骨科经典著作，内含众多

2013年岁末已至，回首这一年，一批「重磅炸弹」级新药的诞生，使得生物制药成为全球医药领域的一个焦点。Top1 默克...晚期黑色素瘤临床试验和非小细胞肺癌试验结果提交给监管机构。Top2 糖尿病治疗的新突破强生和Evotec公司共同开发

2013年岁末已至，回首这一年，一批"重磅炸弹"级新药的诞生，使得生物制药成为全球医药领域的一个焦点。Top...积极的数据。制药巨头正准备将晚期黑色素瘤临床试验和非小细胞肺癌试验结果提交给监管机构。Top2：糖尿病治疗的新突破强生和Evotec公司

CRACKED 网站为大家来盘点了历史上奇葩十大避孕措施，看完之后你会觉得没有什么不可能，妇产君反正已经看到下颌脱臼了。Top 10 黄鼠狼睾丸欧洲正处于「黑暗时代」时期...吧。Top 9 鳄鱼便便创造出了金字塔、木乃伊的古埃及人，在避孕这件事上可以说是煞费苦心，想法也算得上简单粗暴。想要避免怀孕？只要用一些东西堵住不让精子进入

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

Payments by RMB (CNY)

• Payment by telegraphic transfer in CNY must be made to:
  A/C Name:
  A/C No.: 720-031103-001
  Beneficiary Bank:
  Bank Address: No. 1000 Lujiazui Rind Road,
  Pudong, Shanghai 200120, P.R. China
  Bank Swift Code: HSBCCNSH

CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.

, please click: http://www.genomeconference.org/pages/Abstract.aspxTop Poster

trials and regulatory affairs
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China

。【报名回执】访问此链接填写报名回执（https://www.wjx.top/jq/80710449.aspx）【咨询请联系】QQ 号：2814500767邮箱

%），其次是结直肠癌（45%）、肝癌（30%）；正常＜37 U/mL。CA242 消化来源。NSE（神经元特异性烯醇化酶）&nbsp...和特异性，通常联合诊断。癌前病变和初期：CA199、CA242、CA724、CEA 升高。肝癌血清 TMAFP（甲胎蛋白） 原发性肝癌和生殖系

%），其次是结直肠癌（45%）、肝癌（30%）；正常＜37 U/mL。CA242消化来源。NSE（神经元特异性烯醇化酶）&nbsp...和初期：CA199、CA242、CA724、CEA 升高。肝癌血清 TMAFP（甲胎蛋白）原发性肝癌和生殖系肿瘤 TM。正常 ≤ 20

血液标志物，鉴别痴呆和 AD 早期症状的交叉验证研究。其中，衍生队列有 160 名受试者，验证队列有 242 名受试者，包含了 AD 患者以及由 AD 导致的轻度

结直肠癌（45%）、肝癌（30%）。正常＜37 U/mL。CA242 ：消化来源的肿瘤标志物。NSE（神经元特异性烯醇化酶）：小细胞肺癌...;，独立预后因子。没有一种能满足早期诊断的敏感度和特异性，通常联合诊断。癌前病变和初期：CA199、CA242、CA724、CEA 升高

2016 年 12 月 12 日在线发表于《美国心脏病学杂志》的一项研究显示：超说明书剂量（过量或用量不足）使用非维生素 K 口服抗凝剂（NOAC）增加不良临床结局。此项研究评估了房颤患者超剂量使用 NOAC 与临床结局之间的关联。研究共纳入了 5,738 例接受 NOAC 治疗的患者，其中 242 例为房颤患者

各市、县（市、区）科技局（委），省级有关部门，有关高等学校、科研院所，各项目承担单位：根据《浙江省重大科技专项竞争性分配管理办法》规定的竞争性评审立项程序，经我厅研究，决定将「海洋防护材料高通量制备技术研究开发」等 242 个项目（课题）列入 2017 年度浙江省重点研发计划，其中招标项目 29 项、竞争性项目

复旦大学附属中山医院的王妍等开展了一项前瞻性观察研究，比较术前 EOX（卡培他滨、奥沙利铂、表柔比星）与 XELOX（卡培他滨、奥沙利铂）方案化疗对最初不能手术切除的局部晚期胃癌的作用，该研究于当地时间2016年6月4日在第 52 届美国临床肿瘤学会年会（ASCO）上进行壁报展出。该研究共纳入 242 例患者，其中

、Alb 38.30 g/L、TP 58.40 g/L肿瘤标记物：CA19-9 122.27 kU/L、CA242 27.50 kU/L、AFP(-)、乙肝

、胆管癌与 CA19-9胆管癌血清 TM：CA199 诊断价值最高，可联合 CA242、CEA、CA125 辅助诊断。胰腺癌血清 TM：CEA+CA199+TSGF

为 2014 年 10 月。5. 该文筛选出 298 篇文章，但有 242 篇文章未达到质量标准。6. 在研究纳入的 52 篇文章中，6 项为观察性研究，15

（242例，绝经前104例，绝经后138例）中评估多项健康指标。用24-in. (60 cm) flexicurve测量胸椎和腰椎曲率。通过双能X线吸收法